Integrating DTx into APAC healthcare to overcome systemic obstacles

UPDATE - KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital therapeutics and electroceuticals

- KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital therapeutics and electroceuticals - Leading the domestic Korean digital therapeutics (DTx) market through mutual cooperation with Korea’s first ICT technology-medical institution-pharmaceutical company - Accelerated development of DTx related to alcohol and nicotine addiction and heart failure as well as domestic ADHD electroceuticals

KT, Hanmi-invested therapeutics maker Digital Pharm launched